WRIB

Each year WRIB (Workshops on Recent Issues in Bioanalysis) presents a comprehensive program with the most innovative scientific talks from industry leaders and the latest advice from regulators.

Organized by CFABS, a non-profit scientific organization dedicated to promote exchange of knowledge and sharing of ideas in analytical and bioanalytical sciences, it provides one of the best learning, interacting, and networking opportunities on the subject. This year, WRIB will be held in Atlanta, Georgia.

The crucial role of BioAnalysis for the successful implementation of pre-clinical and subsequent clinical pharmacological studies means BioAnalytical teams are under pressure to increase throughput, without compromising quality and data integrity.

Visit us at booth #23 to discover how our secure, compliant Polar BioAnalysis data management platform could transform your bioanalytical operations and increase capacity by driving quality, consistency and cutting your study cycle time by up to 50%.

Polar BioAnalysis combines electronic data capture with structured workflows that drive standard bioanalytical processes. We’ve based these workflows on best practices defined with the world’s leading pharmaceutical, biotech and CROs, and configured them for study definition, sample preparation, data acquisition and analysis, and workflow auditing.

We look forward to seeing you at WRIB!

Kevin Tse, Lead Solutions Consultant

Kevin Tse is a Solutions Consultant at IDBS. As part of the Solutions team, Kevin leverages extensive industry experience and product expertise to identify value-added solutions to each business’ unique challenges and goals.

Prior to joining IDBS, Kevin held a variety of bioanalytical roles in pre-clinical research, analytical development, and quality control within the biopharmaceutical industry.

Kevin holds a BS in Biology from University of Massachusetts Amherst and a MS Bioscience Administration from Worcester Polytechnic Institute.

Kyle Vick, Lead Solutions Consultant

Kyle Vick is a strong advocate of advancing the intersection of software with biology and facilitates the progression of bioanalysis across all genres of science.

Before joining IDBS, Kyle led the data science group in a pharmaceutical company finding novel biological insights using machine learning algorithms. He has been a bench scientist in all reals of pre-clinical pharmaceutical discovery including in vitro, in vivo, and in silico.

Kyle holds a Master in Neuroscience from Florida Atlantic University.

Barbara Jacklich, Strategic Account Manager

At IDBS, Barbara Jacklich manages the CDMO and CRO accounts to meet their GxP and non-GxP electronic lab execution solution needs.

Barbara has been in the industry for 17+ years. She has worked with global accounts form pharma to CRO and CDMO to procure, implement and maintain their 21 CFR Part 11-compliant enterprise systems across drug discovery and serious adverse event reporting.

With a degree in Biochemistry from the University of California, Los Angeles, Barbara understands the unique needs of the life science industry as it moves forward with technology to realize the lab of the future.